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Summary
Osteoporosis-pseudoglioma syndrome (OPS) is an au­
tosomal recessive disorder characterized by severe juve­
nile-onset osteoporosis and congenital or juvenile-onset 
blindness* The pathogenic mechanism is not known* 
Clinical, biochemical, and microscopic analyses suggest 
that OPS may be a disorder of matrix homeostasis rather 
than a disorder of matrix structure. Consequently, iden­
tification of the OPS gene and its protein product could 
provide insights regarding common osteoporotic condi­
tions, such as postmenopausal and senile osteoporosis. 
As a first step toward determining the cause of OPS, we 
utilized a combination of traditional linkage analysis 
and homozygosity mapping to assign the OPS locus to 
chromosome region l lq l2 -1 3 . Mapping was accom­
plished by analyzing 16 DNA samples (seven affected 
individuals) from three different consanguineous kin­
dreds. Studies in 10 additional families narrowed the 
candidate region, supported locus homogeneity, and did 
not detect founder effects. The OPS locus maps to a 13- 
cM interval between D1.1S1298 and D11S971 and most 
likely lies in a 3-cM region between GSTP1 and 
D11S1296. At present, no strong candidate genes colo- 
calize with OPS.
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Introduction
Osteoporosis is a common medical problem with major 
niorbidity and societal cost (Melton 1993). Diminished 
bone strength, a consequence of low bone mineral con­
tent, is the significant complication of the disease (Smith 
and Smith '1976). Heritable factors have been identified 
as major contributors to bone mineral content, account­
ing for most of the observed variance in bone density 
(Peacock '1995). Although biological analyses indicate 
the complexity of this process (Manolagas and Jilka 
1995), the precise genetic factors involved are not 
known (Morrison et al. ’1994; Peacock 1995). Osteopo­
rosis-pseudoglioma syndrome (OPS) (259770, OMIM 
1995) provides an opportunity to study genetic factors 
involved in skeletal homeostasis. This autosomal reces­
sive disorder is characterized by severe juvenile-onset 
osteoporosis and congenital or juvenile-onset blindness 
(Frontali et al. 1985). Collagen I biosynthesis, osteoid, 
osteoblasts, osteocytes, and osteoclasts appear normal 
in patients with OPS (Brude and Stoss 1986; Somer et 
al. 1988; Swoboda and Grill 1988), and visual loss in 
patients has been associated with aberrant vitreo-retinal 
vascular growth (Saraux et al. 1969; Sauvegrain et al. 
1981). These observations suggest a regulatory role, 
rather than a structural role, for the OPS gene product. 
We report the assignment of the OPS locus to chromo­
some region l lq l2 -1 3 , using a combination of tradi­
tional linkage analysis and homozygosity mapping 
(Lander and Botstein 1987).
Subjects and Methods
Patient Ascertainment
All families in this study were diagnosed with OPS on 
the basis of a constellation of clinical, ophthalmologic,
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and radiographic findings (Frontali et al. 1985). After homozygosity for a tightly linked informative marker
informed consent was obtained, blood was obtained for would have yielded a combined lod score >5. Since
DNA extraction. Descriptions of several families partici- there were no a priori candidate genes, we initiated a
pating in this study have been previously published genome-wide scan using SSRPs spaced at 20-cM inter-
(Beighton et al. 1985; Frontali et al. 1985; Superti-Furga vals. For the preliminary scan, regions having lod scores 
et al. 1986; Somer et al. 1988; Swoboda and Grill 1988;
De Paepe et al. 1993).
Genotyping
DNA extraction and linkage analysis were performed 
as described by Boon et al. (1994). Primers flanking 
simple-sequence repeat polymorphisms (SSRPs) were 
used to PCR amplify genomic DNA in 10-|il volumes 
containing 37.5 ng of DNA and 2 pmol of each primer.
Alleles were detected by end-labeling the forward 
primer. Primer sequences were obtained from published 
databases, and primers were purchased from Research 
Genetics.
Typical conditions for PCR included an initial dena- 
turation at 95°C for 4 min, followed by 30 cycles of 
94°C for 40 s, 55°C for 50 s, and 72°C for 50 s, with a 
final extension of 72°C for 7 min. PCR products were 
denatured in the presence of 40% formamide. Then,
1.5-|il aliquots were separated on denaturing polyacryl­
amide gels and alleles were detected by autoradiography.
Linkage Analysis
Two-point lod scores were calculated using the pro­
gram MLINK (Lathrop et al. 1985) with consanguinity 
loops, where known, as indicated in figure 1. Linkage 
calculations assumed autosomal recessive inheritance 
with complete penetrance of the mutant phenotype, a 
phenocopy frequency of '10“*, and a mutant gene fre-
'1 were not evaluated further, while intervals with 
combined lod scores >1 in all three families, or >0 
in family 2 alone, were tested with additional nearby
SSRPs.
One-hundred sixty SSRPs distributed across 20 au­
tos omes were tested before marker D11S905 yielded a 
combined lod score of 1.6 at 0 = .1. Testing additional 
nearby markers suggested identity by descent in affected 
patients (fig. 1). D11S987 yielded the highest combined 
lod score (5.99 at 6 = 0), when ethnically/geographically 
matched control haplotype frequencies were used for 
each kindred.
On the assumption of homozygosity by descent for 
the OPS mutation in each consanguineous kindred, the 
OPS locus can be placed within a 13-cM genetic interval 
bounded by D11S1298 and D11S971 on chromosome 
region l lq l2 -1 3  (Leppert et al. 1994). However, results 
in family 2 indicate that the homozygous markers within 
this 13-cM region comprise two noncontiguous, al­
though physically close, intervals (fig. '1) (Leppert et al. 
1994; van Heyningen and Little 1995). One interval is 
bounded by D11S1298 and D11S1368, the other by 
PYGM and FGF3. The occurrence of heterozygosity be­
tween these two intervals in family 2 may reflect either 
a double recombinant event occurring in an intermediate 
ancestor, or reintroduction of ancestral markers through 
additional consanguineous unions (Beighton et al. 
1985). An alternative, less likely, explanation is that
quency of 10 . Linkage calculations initially^ assumed affected individuals in family 2 are compound heterozy- 
a 4-allele system with equal allele^frequencies. Following gotes for allelic OPS mutations and that markers are
homozygous by chance rather than by descent,
Ten additional kindreds with OPS, including two con-
the identification of linkage, > 20  ethnically/geographi­
cally matched controls for families 1 -6  and 9 were used
to determine specific allele frequencies foi each kindied. sanguineous kindreds, were studied to refine the candi-
SSC Analysis and Cycle Sequence Analysis to Exclude 
PPP1CA, ROM1, F KB PI 3, and CNTF
Previously published primer pairs or sequences (Hen­
drickson et al. 1993; Mochinzuki and Prochaza 1994;
Nichols et al. 1994; Takahashi et* al. 1994) were used 
to amplify portions of the above genes for evaluation by 
either SSC (Orita et al. 1989) or cycle sequence (Murray 
1989) analysis.
date region and to test for locus homogeneity and 
founder effects. Data from families 4 and 9-13 were 
consistent with a single OPS locus on chromosome I I q 
but did not exclude either interval (fig. 2). However, 
results in family 10 potentially narrow both intervals 
(fig. 2). Families 5 -8  were too small to provide linkage 
data but could be used to look for shared haplotypes. 
Analysis of markers compatible with identity by descent 
did not suggest a common founder mutation, even 
among families of similar geographic background (table 
1). However, shared founder haplotypes may emerge as 
the OPS locus is further refined.
Results
Sixteen DNA samples from three different consan­
guineous kindreds (from Finland, South Africa, and It­
aly) were used in the initial mapping (fig. 1). If OPS Discussion 
exhibited locus heterogeneity, only family 2 would have
provided significant statistical strength to achieve a lod We have mapped the OPS locus to chromosome 
score >3. Conversely, if there were locus homogeneity, l lq l2 -1 3  by initially analyzing 16 DNA samples (seven
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Figure 1 Pedigree structures of the first three kindreds studied with genotypes of SSRP and SSCP markers within and flanking the OPS 
region. Sex-averaged genetic distances between several markers are indicated. Consanguinity is denoted by double lines between parents. Bars 
indicate DNA samples available for analysis* Two unaffected siblings in family 2, who were not included among the original 16 samples 
studied, are indicated with an asterisk (*). Paternally derived alleles are on the left of each offspring’s genotype. Fully informative genotypes 
within the family are in bold,'uninformative genotypes are denoted by hyphens (-), incomplete genotypes are left blank. Boxed areas indicate 
markers for which homozygosity by descent cannot be excluded. Markers within the dashed region in family 2 are consistent with identity by 
descent, but not homozygosity by descent. A deduced genotype for the deceased father in family 1 is in italics. SSRP marker D11S987 (in bold) 
is fully informative in each kindred»
affected individuals) from three different consanguine­
ous kindreds. Studies in 10 additional families confirmed
homozygosity by descent, family 10 requires at least two 
recombinant events closely flanking the OPS locus to
the assignment, supported locus homogeneity, and did have occurred in only six meioses. Locus heterogeneity 
not detect founder effects. On the assumption of homo- or compound heterozygosity are alternative explana- 
zygosity by descent in all affected patients from consan- tions for this family’s results; additional DNA samples
guineous unions, the most likely site of the OPS locus 
is between GSTP1 and D11S1296. This interval has a 
genetic distance of 3 cM and a physical distance of >3 
Mb (van Heyningen and Little 1995). Within the inter-
from intermediate relatives, and additional highly poly­
morphic markers within the candidate region, may re­
solve this issue.
At present, no likely candidate genes have been
val, a highly polymorphic SSRP, D11S987, was fully mapped within either OPS candidate interval. On die
informative in every kindred. In contrast, the other ho- assumption of homozygosity by descent for mutations
mozygous interval, between D11S1298 and D11S1335, at the OPS locus in all consanguineous kindreds, several
contained SSRPs that were not fully informative. Conse- genes (CNTF, FKBP13, ROM1, PYGM, PPP1CA,
quently, in some families, homozygosity by chance, GSTP1, and FGF3) can be excluded as candidates on
rather than homozygosity by descent, may have oc- the basis of the finding of heterozygosity for intragenic
cur red. The low heterozygosity content of several other SSRPs or sequence polymorphisms in one or more af-
markers (e.g., D11S913, D11S970, D11S1917) also fected individuals (data not shown). Ophthalmologic
probably results in homozygosity by chance for these disorders have been previously assigned to chromosome
loci in several patients (table 1). On the assumption of llq'12-13, including neovascular inflammatory vitreore-
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Family 9 Family 10
Family 4 Family 11 Family 12
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Figure 2 Pedigree structure and genotypes in ¡six additional families* Four nonconsanguinous, single-offspring families are not shown. 
Sex-averaged genetic distances spanning the two candidate intervals (on the assumption of homozygosity by descent in family 10) are indicated. 
Notations are the same as for figure 1, Affected individuals in family 4 are homozygous for most markers in the region, which is consistent 
with unsuspected consanguinity. Marker GSTP1 (asterisk [*]), appears recombinant in family 9. This is more likely to represent a de novo 
SSRP mutation than a double-recombinant event. A deduced genotype for the deceased mother in family 13 is in italics.
tinopathy (VRNI) and exudative vitreoretinopathy-1 been colocalized to l l q l 3  (Benovic et al. 1991; Cala-
(EVR1) (Li et al. 1992; Stone et al. 1992; Leppert et al. brese et al. 1994). Autosomal x*ecessive forms of isolated
1994; Nichols et al. 1994); however, none colocalize osteoporosis, as well as isolated congenital retinal de-
with OPS. It has been suggested that the abundance of tachment, have also been described (e.g., 259750 and
nonallelic eye disorders on chromosome 1 1 q may be due 221900, OMIM 1995). This may reflect locus heteroge-
to a clustered gene family or a family of interacting neity for these traits. However, certain of these patients
proteins, having roles in ocular development (Nichols may have had unrecognized OPS, since ocular and skele-
et al, 1994). This is particularly intriguing, since OPS 
shares several features with both VRNI and EVR1, and
tal manifestations may not have been manifest at the 
time patients were evaluated. One may also speculate
genes for interacting retinal proteins have previously that OPS3 which is quite rare, is the consequence of
Table 1
OPS-Llnked Marker Alleles in Affected Patients
Family Origin D11S956 D t IS 1965 DM S I335 D l I S 1253 D 11S913 GSTP1 0 11S987 m I S 970
tpin iiimif ifi f nr <nmr i  rut
n i  i s 19 17
I“ Finnish 5 4 1 5 2 5 mm 2
8 Germ a n 6,7 2,7 2,4 « »  i 1,2 4,5 5 3 2,3
I I Austrian 4,5 2 3 1,6 2 1,2 3,4 2,3
13 Dutch 2,8 3,6 2,3 4 * 4 1,2 4 3 1 1,3
5 Belgian 4,8 5,6 3 3 1,2 2,5 4 2 1
6 Belgian u 2,3 1,5 1 3,4 3,4 3 2,3
21 Indian (South African) 5 6 3 2,5 2 4 3 2 3
1 ()a M oroccan 3 6 1,2 2,3 2 1,4 3 2 1
3" Italian 4 1 3 7 1 2 5 2 3
4 Italian I 6 2 4 I 2 2 2 2
9“ Italian 9 1 3 3 1 1,2 3 1 1
7 Puerto Rican 3,9 4,6 3 î t « 1,2 3,4 2,3 2,3 2
12 Guatemalan 3,4 '1,2 2,3 2,3 2 1 3,4 2 1,2
.— Several homozygous marker alleles (e.g., DI1S913, D11S970, D11S1917) also have high homozygosity rates in ethnically/geographi 
cally matched controls (control frequencies were available for families 1-6 and 9), 
u Family with known consanguinity.
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homozygosity for mutations at two tightly linked loci, region with additional markers to reveal homozygosity, 
one responsible for skeletal manifestations, the other for which is presumed to be by descent. This coupled ap- 
ocular features. proach can facilitate the mapping of any rare autosomal
Murine homologues of OPS have not been reported. recessive disorder in which consanguinity or a founder 
Two autosomal recessive murine skeletal disorders, os- mutation is present, because it need not rely on a dense 
teosclerosis (oc) (Marks et al. 1985) and osteochondro- primary mapping screen or on the analysis of a large 
dystrophy (ocd) (Sweet and Bronson 1991) map to mu- number of DNA samples, 
rine chromosome 19, in the region homologous to 
human 11 q 12-13. However, neither is an obvious phe-
nocopy or allelic variant for OPS. Osteosclerosis is char- Acknowledgments_______________ _ _ _____
acterized by hypercalcuria and metaphyseal rickets with 
concurrent osteopetrosis, not osteoporosis. Osteochon­
drodystrophy is characterized by abnormal growth plate 
morphology and stunted growth. Although growth plate 
morphology has not been specifically evaluated in pa­
tients with OPS, disproportionate growth is not a feature 
of the disease. A second region of homology exists be­
tween human 1 lq l3  and murine chromosome 7. Mu­
rine skeletal or ocular phenotypes have not been as­
signed to this region.
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